Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.29
0.02 (0.19%)
At close: Oct 06, 2025, 1:39 PM

Drugs Made In America Acquisition Ordinary Shares Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
Revenue
n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a
Operating Income
-608.05K -476.19K -145.26K -144.98K -54.93
Interest Income
4.01M 1.59M n/a n/a n/a
Pretax Income
3.4M 1.11M -145.26K -144.98K -54.93
Net Income
3.4M 1.11M -145.26K -144.98K -54.93
Selling & General & Admin
608.05K 476.19K 145.26K 144.98K 54.93
Research & Development
n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
608.05K 476.19K 145.26K 144.98K 54.93
Interest Expense
n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
608.05K 476.19K 145.26K 144.98K 54.93
Income Tax Expense
n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
33.52M 9.61K 8.57K 8.57K 8.57K
Shares Outstanding (Diluted)
33.52M 25.51K 8.57K 8.57K 8.57K
EPS (Basic)
130.54 130.47 -0.04 -0.01 -0.01
EPS (Diluted)
49.21 49.14 -0.04 -0.01 -0.01
EBITDA
-607.77K -475.85K -144.93K -144.93K n/a
EBIT
-608.05K -476.19K -145.26K -144.98K -54.93
Depreciation & Amortization
279.88 334.81 334.81 54.93 54.93